Journal Papers

home > Publication > Journal Papers

No. Title (Impact Factor > 9.5)
81

K. M. Park, J.-A. Yang, H. Jung, J. Yeom, J. S. Park, K.-H. Park, A. S. Hoffman, S. K. Hahn*, and K. Kim*, “In Situ Supramolecular Assembly and Modular Modification of Hyaluronic Acid Hydrogels for 3D Cellular Engineering”, ACS Nano, 6, 2960-2968 (2012) (Impact factor: 17.1) - Highlighted in the ECM News.

82 J.-A. Yang, K. Park, H. Jung, H. Kim, S. W. Hong, S. K. Yoon, S. K. Hahn*, “Target Specific Hyaluronic Acid - Interferon Alpha Conjugate for the Treatment of Hepatitis C Virus Infection”, Biomaterials, 32, 8722-8729 (2011) (Impact factor: 14.0).
83

M.-Y. Lee, S.-J. Park, K. Park, K. S. Kim, H. Lee, and S. K. Hahn*, “Target Specific Gene Silencing of Layer-by-Layer Assembled Gold-Cysteamine/siRNA/PEI/HA Nanocomplex”, ACS Nano, 5, 6138-6147 (2011) (Impact factor: 17.1).

84

H. Jung, K. M. Park, J.-A. Yang, E. J. Oh, D.-W. Lee, K. Park, S. H. Ryu, S. K. Hahn*, K. Kim*, “ Theranostic Systems Assembled In Situ On Demand by Host-Guest Chemistry”, Biomaterials, 32, 7687-7694 (2011) (Impact factor: 14.0).

85

J. K. Park, J.-H. Shim, K. S. Kang, J. Yeom, H. S. Jung, J. Y. Kim, K. H. Lee, T.-H. Kim, S.-Y. Kim, D.-W. Cho*, and S. K. Hahn*, "Solid Free-Form Fabrication of Tissue-Engineering Scaffolds with a Poly(lactec-co-glycolic acid) Grafted Hyaluronic Acid Conjugate Encapsulating an Intact Bone Morphogenetic Protein-2/Poly(ethylene glycol) Complex", Advanced Functional Materials, 21, 2906-2912 (2011) (Impact factor: 19.0). 

86

K. Park, S. W. Hong, W. Hur, M.-Y. Lee, J.-A. Yang, S. W. Kim, S. K. Yoon*, and S. K. Hahn*, “Target Specific Systemic Delivery of TGF-β siRNA/(PEI-SS)-g-HA Complex for the Treatment of Liver Cirrhosis”, Biomaterials, 32, 4951-4958 (2011) (Impact factor: 14.0).

87

E. J. Oh, J.-S. Choi, H. Kim, C.-K. Joo*, and S. K. Hahn*, “Anti Flt1 Peptide-Hyaluronate Conjugate for the Treatment of Retinal Neovascularization and Diabetic Retinopathy”, Biomaterials, 32, 3115-3123 (2011) (Impact factor: 14.0).

88

K. S. Kim, S. J. Park, J.-A. Yang, J.-H. Jeon, S. H. Bhang, B.-S. Kim, S. K. Hahn*, " Injectable Hyaluronic Acid - Tyramine Hydrogels for the Treatment of Rheumatoid Arthritis", Acta Biomaterialia, 7, 666-674 (2011) (Impact factor: 9.7).

89

E. J. Oh, K. Park, K. S. Kim, J. Kim, J.-A. Yang, J.-H. Kong, M. Y. Lee, A. S. Hoffman, and S. K. Hahn*, “Target Specific and Long-Acting Delivery of Protein, Peptide, and Nucleotide Therapeutics Using Hyaluronic Acid Derivatives”, Journal of Controlled Release, 141, 2-12 (2010) (Impact factor: 10.8).

90

J. K. Park, Y.-J. Kim, J. Yeom, J. H. Jeon, G.-C. Yi, J. H. Je, and S. K. Hahn*, “The Topographic Effect of Zinc Oxide Nanoflowers on Osteoblast Growth and Osseointegration”, Advanced Materials, 22, 4857-4861 (2010) (Impact factor: 29.4).

91

S. Y. Yang, J.-A. Yang, E.-S. Kim, G. Jeon, E. J. Oh, K. Y. Choi, S. K. Hahn*, and J. K. Kim*, “Single File Diffusion of Protein Drugs through Cylindrical Nanochannels”, ACS Nano, 4, 3817-3822 (2010) - Highlighted in the Perspectives (Impact factor: 17.1).

92

K. S. Kim, W. Hur, S.-J. Park, S. W. Hong, J. E. Choi, E. J. Goh, S. K. Yoon*, and S. K. Hahn*, “Bio-imaging for Targeted Delivery of Hyaluronic Acid Derivatives to the Liver in Cirrhotic Mice Using Quantum Dots”, ACS Nano, 4, 3005-3014 (2010) (Impact factor: 17.1).

93

K. Park, M.-Y. Lee, K. S. Kim, and S. K. Hahn*, “Target Specific Tumor Treatment by VEGF siRNA Complexed with Reducible Polyethyleneimine-Hyaluronic Acid Conjugate”, Biomaterials, 31, 5258-5265 (2010) (Impact factor: 14.0).

94

J.-H. Kong, E. J. Oh, S. Y. Chae, K. C. Lee, and S. K. Hahn*, “Long Acting Hyaluronate-Exendin 4  Conjugate for the Treatment of Type 2 Diabetes”, Biomaterials, 31, 4121-4128 (2010) (Impact factor: 14.0).

95

H.-S. Lee, K. S. Kim (co-first author), C.-J. Kim, S. K. Hahn, and M.-H. Jo*, "Electrical Detection of VEGFs for Cancer Diagnoses Using Anti-vascular Endotherial Growth Factor Aptamer-modified Si Nanowire FETs", Biosensors & Bioelectronics, 24, 1801-1805 (2009) (Impact factor: 12.6).

96

E. J. Oh, K. Park, J.-S. Choi, C.-K. Joo, and S. K. Hahn*, “Synthesis, Characterization, and Preliminary Assessment of Anti-Flt1 Peptide Hyaluronate Conjugate for the Treatment of Corneal Neovascularization", Biomaterials, 30, 6026-6034 (2009) (Impact factor: 14.0).

97

S. H. Bhang, N. Won, T.-J. Lee, H. Jin, J. Nam, J. Park, H. Chung, H.-S. Park, Y.-E. Sung, S. K. Hahn, B.-S. Kim*, and S. Kim*, “Hyaluronic Acid - Quantum Dot Conjugates for In Vivo Lymphatic Vessel Imaging”, ACS Nano, 3, 1389-1398 (2009) (Impact factor: 17.1).

98

S. J. Kim, S. K. Hahn*, M. J. Kim, D. H. Kim, Y. P. Lee, "Development of A Novel Sustained Release Formulation of Recombinant Human Growth Hormone Using Sodium Hyaluronate Microparticles", Journal of Controlled Release, 104, 323-335 (2005) (Impact factor: 10.8).

이전페이지 1 2 3 4 5 다음페이지


TOP